Skip to content
DataLookout
Menu

NCT06639230

Effect of Laser and Sclerotic Agent in the Treatment of Oral Granuloma

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 1 with changes below, 1 re-verified with no change.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Postoperative pain was evaluated (NRS)
Timeframe: 3 months
Recurrence rate
Timeframe: 3 months
Patient compliance (VAS).
Timeframe: 3 months

Secondary (1)

Details of side effects

Arms and interventions

Group 1: Laser-treated groupActive comparator

10 patients will be treated by laser surgery to remove oral granuloma

Sclerotherapy-treated group (group 2)Active comparator

This group was made up of ten patients who were treated with injections of sclerosing agent to remove pyogenic granuloma

Devices: laser therapy

Drugs: Sclerotherapy